Logo image of IQV

IQVIA HOLDINGS INC (IQV) Stock Fundamental Analysis

NYSE:IQV - US46266C1053 - Common Stock

190.575 USD
+5.19 (+2.8%)
Last: 8/22/2025, 10:26:04 AM
Fundamental Rating

5

IQV gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 54 industry peers in the Life Sciences Tools & Services industry. IQV scores excellent on profitability, but there are concerns on its financial health. IQV has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year IQV was profitable.
In the past year IQV had a positive cash flow from operations.
Each year in the past 5 years IQV has been profitable.
IQV had a positive operating cash flow in each of the past 5 years.
IQV Yearly Net Income VS EBIT VS OCF VS FCFIQV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

1.2 Ratios

IQV's Return On Assets of 4.32% is fine compared to the rest of the industry. IQV outperforms 74.07% of its industry peers.
With an excellent Return On Equity value of 21.41%, IQV belongs to the best of the industry, outperforming 90.74% of the companies in the same industry.
The Return On Invested Capital of IQV (9.40%) is better than 83.33% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IQV is significantly below the industry average of 15.98%.
The last Return On Invested Capital (9.40%) for IQV is above the 3 year average (8.99%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.32%
ROE 21.41%
ROIC 9.4%
ROA(3y)4.83%
ROA(5y)3.91%
ROE(3y)21.26%
ROE(5y)16.88%
ROIC(3y)8.99%
ROIC(5y)7.35%
IQV Yearly ROA, ROE, ROICIQV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

The Profit Margin of IQV (7.88%) is better than 68.52% of its industry peers.
In the last couple of years the Profit Margin of IQV has grown nicely.
IQV has a better Operating Margin (14.41%) than 75.93% of its industry peers.
IQV's Operating Margin has improved in the last couple of years.
The Gross Margin of IQV (34.25%) is worse than 62.96% of its industry peers.
In the last couple of years the Gross Margin of IQV has remained more or less at the same level.
Industry RankSector Rank
OM 14.41%
PM (TTM) 7.88%
GM 34.25%
OM growth 3Y13.09%
OM growth 5Y13.9%
PM growth 3Y8.58%
PM growth 5Y38.92%
GM growth 3Y1.42%
GM growth 5Y0.42%
IQV Yearly Profit, Operating, Gross MarginsIQV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IQV is destroying value.
The number of shares outstanding for IQV has been reduced compared to 1 year ago.
Compared to 5 years ago, IQV has less shares outstanding
The debt/assets ratio for IQV is higher compared to a year ago.
IQV Yearly Shares OutstandingIQV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
IQV Yearly Total Debt VS Total AssetsIQV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

IQV has an Altman-Z score of 1.91. This is not the best score and indicates that IQV is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of IQV (1.91) is comparable to the rest of the industry.
The Debt to FCF ratio of IQV is 7.71, which is on the high side as it means it would take IQV, 7.71 years of fcf income to pay off all of its debts.
IQV has a Debt to FCF ratio (7.71) which is in line with its industry peers.
IQV has a Debt/Equity ratio of 2.45. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.45, IQV is not doing good in the industry: 85.19% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.45
Debt/FCF 7.71
Altman-Z 1.91
ROIC/WACC0.92
WACC10.23%
IQV Yearly LT Debt VS Equity VS FCFIQV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

IQV has a Current Ratio of 0.84. This is a bad value and indicates that IQV is not financially healthy enough and could expect problems in meeting its short term obligations.
IQV has a worse Current ratio (0.84) than 90.74% of its industry peers.
IQV has a Quick Ratio of 0.84. This is a bad value and indicates that IQV is not financially healthy enough and could expect problems in meeting its short term obligations.
IQV's Quick ratio of 0.84 is on the low side compared to the rest of the industry. IQV is outperformed by 85.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.84
IQV Yearly Current Assets VS Current LiabilitesIQV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

5

3. Growth

3.1 Past

IQV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.13%, which is quite good.
The Earnings Per Share has been growing by 11.72% on average over the past years. This is quite good.
Looking at the last year, IQV shows a small growth in Revenue. The Revenue has grown by 3.60% in the last year.
Measured over the past years, IQV shows a small growth in Revenue. The Revenue has been growing by 6.80% on average per year.
EPS 1Y (TTM)9.13%
EPS 3Y7.25%
EPS 5Y11.72%
EPS Q2Q%6.44%
Revenue 1Y (TTM)3.6%
Revenue growth 3Y3.55%
Revenue growth 5Y6.8%
Sales Q2Q%5.32%

3.2 Future

Based on estimates for the next years, IQV will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.16% on average per year.
IQV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.60% yearly.
EPS Next Y7.3%
EPS Next 2Y8.52%
EPS Next 3Y9.22%
EPS Next 5Y10.16%
Revenue Next Year5.16%
Revenue Next 2Y5.1%
Revenue Next 3Y5.36%
Revenue Next 5Y5.6%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
IQV Yearly Revenue VS EstimatesIQV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B 25B
IQV Yearly EPS VS EstimatesIQV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5 10 15 20

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.62, which indicates a correct valuation of IQV.
Based on the Price/Earnings ratio, IQV is valued cheaper than 88.89% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.76. IQV is valued slightly cheaper when compared to this.
IQV is valuated correctly with a Price/Forward Earnings ratio of 14.53.
IQV's Price/Forward Earnings ratio is rather cheap when compared to the industry. IQV is cheaper than 90.74% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.91. IQV is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 16.62
Fwd PE 14.53
IQV Price Earnings VS Forward Price EarningsIQV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

90.74% of the companies in the same industry are more expensive than IQV, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IQV indicates a rather cheap valuation: IQV is cheaper than 87.04% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.12
EV/EBITDA 13.2
IQV Per share dataIQV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
IQV has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.28
PEG (5Y)1.42
EPS Next 2Y8.52%
EPS Next 3Y9.22%

More info and screens

0

5. Dividend

5.1 Amount

IQV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IQVIA HOLDINGS INC

NYSE:IQV (8/22/2025, 10:26:04 AM)

190.575

+5.19 (+2.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)07-22 2025-07-22/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners98.17%
Inst Owner Change6.06%
Ins Owners0.88%
Ins Owner Change0.1%
Market Cap32.40B
Analysts79.31
Price Target221.95 (16.46%)
Short Float %4.05%
Short Ratio3.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1%
Min EPS beat(2)0.45%
Max EPS beat(2)1.56%
EPS beat(4)3
Avg EPS beat(4)0.36%
Min EPS beat(4)-0.62%
Max EPS beat(4)1.56%
EPS beat(8)6
Avg EPS beat(8)0.66%
EPS beat(12)9
Avg EPS beat(12)0.84%
EPS beat(16)13
Avg EPS beat(16)1.1%
Revenue beat(2)2
Avg Revenue beat(2)0.45%
Min Revenue beat(2)0.4%
Max Revenue beat(2)0.5%
Revenue beat(4)2
Avg Revenue beat(4)0.12%
Min Revenue beat(4)-0.4%
Max Revenue beat(4)0.5%
Revenue beat(8)3
Avg Revenue beat(8)-0.14%
Revenue beat(12)4
Avg Revenue beat(12)-0.19%
Revenue beat(16)7
Avg Revenue beat(16)-0.12%
PT rev (1m)14.58%
PT rev (3m)1.27%
EPS NQ rev (1m)-2.32%
EPS NQ rev (3m)-3.42%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.08%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)1.08%
Revenue NY rev (1m)0.67%
Revenue NY rev (3m)0.6%
Valuation
Industry RankSector Rank
PE 16.62
Fwd PE 14.53
P/S 2.06
P/FCF 16.12
P/OCF 12.38
P/B 5.61
P/tB N/A
EV/EBITDA 13.2
EPS(TTM)11.47
EY6.02%
EPS(NY)13.12
Fwd EY6.88%
FCF(TTM)11.82
FCFY6.2%
OCF(TTM)15.39
OCFY8.08%
SpS92.35
BVpS33.99
TBVpS-84.88
PEG (NY)2.28
PEG (5Y)1.42
Profitability
Industry RankSector Rank
ROA 4.32%
ROE 21.41%
ROCE 10.75%
ROIC 9.4%
ROICexc 10.5%
ROICexgc N/A
OM 14.41%
PM (TTM) 7.88%
GM 34.25%
FCFM 12.8%
ROA(3y)4.83%
ROA(5y)3.91%
ROE(3y)21.26%
ROE(5y)16.88%
ROIC(3y)8.99%
ROIC(5y)7.35%
ROICexc(3y)9.76%
ROICexc(5y)7.99%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.28%
ROCE(5y)8.4%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y16.83%
ROICexc growth 5Y22.05%
OM growth 3Y13.09%
OM growth 5Y13.9%
PM growth 3Y8.58%
PM growth 5Y38.92%
GM growth 3Y1.42%
GM growth 5Y0.42%
F-Score4
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 2.45
Debt/FCF 7.71
Debt/EBITDA 4.19
Cap/Depr 54.1%
Cap/Sales 3.87%
Interest Coverage 250
Cash Conversion 77.31%
Profit Quality 162.49%
Current Ratio 0.84
Quick Ratio 0.84
Altman-Z 1.91
F-Score4
WACC10.23%
ROIC/WACC0.92
Cap/Depr(3y)57.12%
Cap/Depr(5y)53.97%
Cap/Sales(3y)4.31%
Cap/Sales(5y)4.59%
Profit Quality(3y)136.6%
Profit Quality(5y)225.89%
High Growth Momentum
Growth
EPS 1Y (TTM)9.13%
EPS 3Y7.25%
EPS 5Y11.72%
EPS Q2Q%6.44%
EPS Next Y7.3%
EPS Next 2Y8.52%
EPS Next 3Y9.22%
EPS Next 5Y10.16%
Revenue 1Y (TTM)3.6%
Revenue growth 3Y3.55%
Revenue growth 5Y6.8%
Sales Q2Q%5.32%
Revenue Next Year5.16%
Revenue Next 2Y5.1%
Revenue Next 3Y5.36%
Revenue Next 5Y5.6%
EBIT growth 1Y7.86%
EBIT growth 3Y17.1%
EBIT growth 5Y21.64%
EBIT Next Year21.21%
EBIT Next 3Y11.05%
EBIT Next 5Y9.36%
FCF growth 1Y27.05%
FCF growth 3Y-2.8%
FCF growth 5Y20.42%
OCF growth 1Y16.73%
OCF growth 3Y-2.63%
OCF growth 5Y13.9%